Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28334365

Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2017 May 1
First author
Joensuu H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2017 May 1;3(5):597-599. doi: 10.1001/jamaoncol.2016.5740.
    note
    Source null
    related pmid
    28334361
    relationship
    Comment in
  2. citation
    Transl Gastroenterol Hepatol. 2017 Oct 13;2:81. doi: 10.21037/tgh.2017.09.10.
    note
    Source null
    related pmid
    29167828
    relationship
    Comment in

Authors and identifiers

  1. name
    Joensuu H
    type
    Author
  2. name
    Wardelmann E
    type
    Author
  3. name
    Sihto H
    type
    Author
  4. name
    Eriksson M
    type
    Author
  5. name
    Sundby Hall K
    type
    Author
  6. name
    Reichardt A
    type
    Author
  7. name
    Hartmann JT
    type
    Author
  8. name
    Pink D
    type
    Author
  9. name
    Cameron S
    type
    Author
  10. name
    Hohenberger P
    type
    Author
  11. name
    Al-Batran SE
    type
    Author
  12. name
    Schlemmer M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Joensuu H
    type
    Author
  2. name
    Wardelmann E
    type
    Author
  3. name
    Sihto H
    type
    Author
  4. name
    Eriksson M
    type
    Author
  5. name
    Sundby Hall K
    type
    Author
  6. name
    Reichardt A
    type
    Author
  7. name
    Hartmann JT
    type
    Author
  8. name
    Pink D
    type
    Author
  9. name
    Cameron S
    type
    Author
  10. name
    Hohenberger P
    type
    Author
  11. name
    Al-Batran SE
    type
    Author
  12. name
    Schlemmer M
    type
    Author
bibliography ids
  1. nci-bib-ef0dca75eacb40ff082f8a97
book metadata
content sha256
9aab96a80105e46b50aee68bd541341be30210a2befb3f9afe545165d32ed441
document type
citation
dois
  1. 10.1001/jamaoncol.2016.5751
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:28334365
immutable id
pubmed:28334365@9aab96a80105e46b50aee68bd541341be30210a2befb3f9afe545165d32ed441
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
5
name
JAMA oncology
nlm unique id
101652861
pages
602-609
volume
3
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2017 May 1;3(5):597-599. doi: 10.1001/jamaoncol.2016.5740.
    note
    Source null
    related pmid
    28334361
    relationship
    Comment in
  2. citation
    Transl Gastroenterol Hepatol. 2017 Oct 13;2:81. doi: 10.21037/tgh.2017.09.10.
    note
    Source null
    related pmid
    29167828
    relationship
    Comment in
outcomes validated
false
pmid
28334365
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
052980996de014d5904f921bafad8c5279ac64675b720c4cd54316676bb96820
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 May 1
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28334365/
title
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.

Preserved source evidence · Not medical advice